BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu J, Shen L, Shui Y, Yu W, Guo Q, Yu R, Wu Y, Wei Q. Patterns of recurrence after curative D2 resection for gastric cancer: Implications for postoperative radiotherapy. Cancer Med 2020;9:4724-35. [PMID: 32420703 DOI: 10.1002/cam4.3085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Misra S, Yeshala SK, Singh S, Singh RK, Maria Das KJ, Kumar S, Kumar S. A Pilot Study of Perioperative Cisplatin-Capecitabine Chemotherapy With Preoperative Chemoradiation for Resectable Gastric Cancers. Am J Clin Oncol 2021;44:475-81. [PMID: 34183522 DOI: 10.1097/COC.0000000000000844] [Reference Citation Analysis]
2 Xu J, Shen L, Shui Y, Yu W, Guo Q, Yu R, Wu Y, Wei Q. Patterns of recurrence after curative D2 resection for gastric cancer: Implications for postoperative radiotherapy. Cancer Med 2020;9:4724-35. [PMID: 32420703 DOI: 10.1002/cam4.3085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yekedüz E, Dogan İ, Kaya DM, Özgür İ, Utkan G, Vatansever S, Demirci S, Akbulut H, Ürün Y. Systemic Immune-Inflammation Index as a Prognostic Marker of Late Recurrence in Operable Gastric Cancer: a Dual-Center Study. J Gastrointest Cancer 2021. [PMID: 34845631 DOI: 10.1007/s12029-021-00769-w] [Reference Citation Analysis]
4 Pan S, Yin S, Zhu Z, Liu F, Xu H. Decision-making of adjuvant therapy in pT1N1M0 gastric cancer: Should radiotherapy be added to chemotherapy? A propensity score-matched analysis. J Cancer 2021;12:1179-89. [PMID: 33442416 DOI: 10.7150/jca.52123] [Reference Citation Analysis]
5 Romanzi A, Mancini R, Ioni L, Picconi T, Pernazza G. ICG-NIR-guided lymph node dissection during robotic subtotal gastrectomy for gastric cancer. A single-centre experience. Int J Med Robot 2021;17:e2213. [PMID: 33372409 DOI: 10.1002/rcs.2213] [Reference Citation Analysis]